Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Extra Space Storage, Inc. (EXR) vs Mesoblast Limited (MESO) Price & Performance

Extra Space Storage, Inc.Trade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Extra Space Storage, Inc. vs Mesoblast Limited — how do they compare? Extra Space Storage, Inc. trades at $147.42 (market cap $30.56B), while Mesoblast Limited trades at $19.12 (market cap $2.31B). The key difference: Extra Space Storage, Inc. is far larger — about 13.2× Mesoblast Limited's market cap, and Extra Space Storage, Inc. pays a 4.48% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

EXRMESO
Market Cap
$30.56B$2.31B
Sector
Real EstateTechnology
52-Week High
$152.75$20.96
52-Week Low
$126.67$11.35
Enterprise Value
$44.36B$2.32B
Dividend Yield
4.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Extra Space Storage, Inc.

No Aura AI signal available yet.

Mesoblast Limited

Mesoblast (MESO) trades at $19.12, up 14.22% with strong bullish technical signals from moving averages. The biotech company shows promising commercial progress with FDA-approved Ryoncil generating $115M annual revenue, though fundamentals reveal significant losses with a -144.33% net income margin and negative EBITDA of -$80.06M. Recent milestones include achieving Phase 3 trial targets for chronic low back pain and receiving a BLA filing number for heart failure treatment.

Investment outlook balances high growth potential from Mesoblast's cellular medicine platform against substantial financial losses and valuation concerns. The company's transition to commercial operations and pipeline advancements present opportunities, while persistent cash burn and negative profitability represent key risks requiring careful monitoring of upcoming clinical and regulatory catalysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Extra Space Storage, Inc.

Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.

Read more on EXR

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO